Table of Contents

company-logo

Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered in Richmond Hill, Canada.

Helix BioPharma Dividend Announcement

• Helix BioPharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Helix BioPharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Helix BioPharma Dividend History

Helix BioPharma Dividend Yield

Helix BioPharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Helix BioPharma stock? Use our calculator to estimate your expected dividend yield:

Helix BioPharma Financial Ratios

P/E ratio-3.78
PEG ratio-0.95
P/B ratio-389.19
ROE42597.70%
Payout ratio0.00%
Current ratio0.92
Quick ratio0.92
Cash Ratio0.68

Helix BioPharma Dividend FAQ

Does Helix BioPharma stock pay dividends?
Helix BioPharma does not currently pay dividends to its shareholders.
Has Helix BioPharma ever paid a dividend?
No, Helix BioPharma has no a history of paying dividends to its shareholders. Helix BioPharma is not known for its dividend payments.
Why doesn't Helix BioPharma pay dividends?
There are several potential reasons why Helix BioPharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Helix BioPharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Helix BioPharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Helix BioPharma a dividend aristocrat?
Helix BioPharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Helix BioPharma a dividend king?
Helix BioPharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Helix BioPharma a dividend stock?
No, Helix BioPharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Helix BioPharma stocks?
To buy Helix BioPharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Helix BioPharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.